View source for The Biggest Lie In Xarelto Lawsuit

Our attorneys have filed a mass tort lawsuit on behalf of patients who took the blood thinner Xarelto (rivaroxaban) and suffered serious bleeding events. Pharmaceutical businesses, like the makers of Xarelto, have a duty to make sure that their drugs are reasonably secure for use - and failure to perform so might be grounds for compensation. Our lawyers are working difficult to acquire these hurt by the drug the compensation they may be entitled to.<br><br>While bleeding is actually a widespread complication associated with anticoagulants, it has been alleged that Xarelto is far more unsafe than standard blood thinners simply because no antidote exists to reverse its blood-thinning effects. This implies that, in the event of an emergency, individuals may be at threat for irreversible bleeding issues, like life-threatening internal and gastrointestinal hemorrhaging.<br><br>Should you or possibly a loved one suffered a severe bleeding event following taking Xarelto, you may have legal recourse. For more information, contact us today to have your case reviewed, totally free of charge.<br>Compensation Possibilities<br><br>xarelto-compensation-photoThe plaintiffs in these lawsuits are in search of compensation from Bayer and Janssen for past and future healthcare bills, lost wages, pain and suffering and, in cases of death, funeral expenses. Additionally, they are searching for punitive damages, that are generally awarded to punish the defendant and deter other companies from acting similarly.<br>Why Are Lawsuits Being Filed?<br><br>Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that  [http://xareltolawsuit.bitbucket.org/categories/MD/Xarelto-Stroke-Lawsuit-Bowie-MD-20721.html http://xareltolawsuit.bitbucket.org] the drug is harmful and defective. The plaintiffs claim that, unlike traditional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Because of this, the lawsuits claim, doctors have no effective implies of stopping Xarelto users from bleeding in the occasion of an emergency. Plaintiffs within the lawsuits allege serious and fatal injuries, which includes cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.<br><br>In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:<br><br>The manufacturers of Xarelto marketed the drug as a superior in the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.<br>The makers of the drug continue to market Xarelto as a secure anticoagulant option.<br>Doctors and health-related staff were not properly made aware of methods to [http://pinterest.com/search/pins/?q=stabilize stabilize] and treat a Xarelto user within the event of a bleeding complication.<br>Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.<br>Xarelto is linked to severe bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing dangerous clotting.<br><br>Visit this page for a lot more information on the alleged health risks of Xarelto.<br>Multidistrict Litigation Trial Dates Set<br><br>The attorneys in the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.